Trademark: 79056105
Word
EURO-DIAGNOSTICA
Status Date
Monday, February 26, 2018
Registration Number
3889214
Registration Date
Tuesday, December 14, 2010
Filing Date
Tuesday, February 26, 2008
Published for Opposition
Tuesday, September 28, 2010
Cancellation Date
Monday, February 26, 2018
1 Diagnostic chemicals, namely, diagnostic preparations for scientific or research use, diagnostic reagents for scientific or research use; diagnostic preparations for scientific and research laboratory use, laboratory chemicals, namely, antibody reagents for detection in bodily fluid, blood, blood serum, cell and tissue analysis for in vitro diagnostic use, reagents for chemical analyses, diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology, assays for research purposes; chemical substances for laboratory analyses other than for medical or veterinary purposes; testing kits containing peptide substrates used in analyzing and detecting certain toxins for clinical or medical laboratory use; testing kits containing peptide substrates used in analyzing and detecting certain toxins for clinical or medical laboratory use; biomedical compounds, namely, peptide substrates used in analyzing and detecting certain toxins for laboratory or research use, and used in clinical or medical laboratory use; biochemicals, namely, polypeptides for in vitro research use; biochemicals, namely, monoclonal antibodies for in vitro scientific or research use and polyclonal antibodies for scientific or research use; biomedical compounds, namely, peptide substrates used in analyzing and detecting certain toxins for laboratory or research use; biomedical compounds, namely, peptide substrates used in analyzing and detecting certain toxins for clinical or medical laboratory use; chemical reagents for non-medical purposes; chemicals for use in industry and science; chemicals for use in industry; chemicals, namely, buffer and standard solutions used in analytical chemistry; chemicals, namely, immunodiagnostic and inorganic reagents for scientific or medical research use in the field of human diagnostics; chemicals, namely, immunodiagnostic or inorganic reagents for scientific and industrial use, namely, for food testing; diagnostic preparations other than for medical or veterinary purposes; diagnostic preparations used in science; diagnostic preparations for clinical or medical laboratory use; diagnostic reagents for clinical or medical laboratory use; diagnostic reagents and preparations, except for medical or veterinary use; diagnostic test kits comprising research reagents for industrial use, namely, for food testing; diagnostic test kits comprising research reagents for industrial use, namely, for animal feed testing; disposable cartridges or cassettes containing reagents and assays for scientific research in the nature of environmental or food testing; laboratory chemicals, namely, an antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use; nucleic acid for laboratory use; nucleic acid sequences and chemical reagents for other than medical and veterinary purposes; protein arrays and nucleotide arrays for scientific and medical research; reagents for research purposes; reagents for scientific or medical research use; reagents for use in scientific apparatus for chemical or biological analysis; research reagents for industrial use, namely, for food testing
5 Chemical preparations for medical and veterinary purposes, namely, chemical reagents; chemical reagents for medical and veterinary purposes, clinical medical reagents, diagnostic preparations for medical purposes, biological preparations for medical or veterinary purposes; kits comprised principally of medical diagnostic assays for testing of bodily fluids; medical diagnostic test kits, comprised principally of medical diagnostic test strips, for use in the field of autoimmune disease, joint inflammatory disease, renal disease, respiratory infectious disease, rheumatoid arthritis, and pertussis; in vitro diagnostic test kits comprised primarily of medical diagnostic reagents for use in the field of autoimmune disease, joint inflammatory disease, renal disease, respiratory infectious disease, rheumatoid arthritis, and pertussis; medical diagnostic reagents and assays for testing of body fluids, drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; diagnostic preparations for medical purposes for detecting the presence of autoimmune disorders and conditions in humans; lateral flow test kits comprised of medical diagnostic test strips and lateral flow cassettes, designed to assess the concentrations of target components in qualitative or quantitative assays for use in the field of autoimmune disease, joint inflammatory disease, renal disease, respiratory infectious disease, rheumatoid arthritis, and pertussis; biochemical preparations for medical or veterinary purposes; diagnostic agents, preparations and substances for medical purposes; diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; diagnostic preparations for medical purposes for detecting the presence of malignant, inflammatory and autoimmune disorders and conditions and tissue trauma in humans; diagnostic reagents for medicinal use; medical diagnostic reagents; medical diagnostic reagents and assays for testing of body fluids; medical diagnostic test strips for use in the field of autoimmune disease, joint disease, arthritis, renal disease, respiratory infectious disease, and pertussis; reagents and media for medical and veterinary diagnostic purposes; reagents for medical use
10 Medical apparatus and instruments, namely, apparatus for blood analysis; blood testing apparatus; apparatus for clinical diagnosis
The color(s) blue, grey, black, white is/are claimed as a feature of the mark.
"EURO-DIAGNOSTICA"
The mark consists of the colors blue, gray, black and white, with the color blue appearing in the words "EURO-DIAGNOSTICA", and in the top surface of the stylized antibody/antigen designs on the right of the mark, the color black appearing in the outline of the stylized antibody/antigen designs and in the partial rectangle border around "EURO-DIAGNOSTICA", the color gray appearing in the shadow of the stylized antibody/antigen designs and the color white appearing in the background.
The English translation of "EURO-DIAGNOSTICA" in the mark is "EUROPEAN DIAGNOSTICS".
Sep 28, 2018
Notification Of Effect Of Cancellation Of Intl Reg Mailed
Sep 28, 2018
Death Of International Registration
Apr 19, 2018
Total Invalidation Processed By The Ib
Mar 29, 2018
Total Invalidation Of Reg Ext Protection Sent To Ib
Mar 29, 2018
Invalidation Processed
Mar 21, 2018
Total Invalidation Of Reg Ext Protection Created
Jul 21, 2017
Cancelled Section 71
Mar 22, 2013
New Representative At Ib Received
Feb 17, 2013
Final Decision Transaction Processed By Ib
Apr 13, 2011
Final Disposition Notice Sent To Ib
Apr 13, 2011
Final Disposition Processed
Mar 14, 2011
Final Disposition Notice Created, To Be Sent To Ib
Dec 14, 2010
Registered-Principal Register
Sep 28, 2010
Official Gazette Publication Confirmation E-Mailed
Sep 28, 2010
Published For Opposition
Aug 23, 2010
Law Office Publication Review Completed
Aug 20, 2010
Approved For Pub - Principal Register
Aug 7, 2010
Teas/Email Correspondence Entered
Aug 7, 2010
Correspondence Received In Law Office
Aug 3, 2010
Teas Request For Reconsideration Received
Feb 19, 2010
Notification Of Final Refusal Emailed
Feb 19, 2010
Final Refusal E-Mailed
Feb 19, 2010
Final Refusal Written
Jan 30, 2010
Teas/Email Correspondence Entered
Jan 30, 2010
Correspondence Received In Law Office
Jan 29, 2010
Teas Response To Office Action Received
Jan 29, 2010
Notification Of Possible Opposition - Processed By Ib
Jan 14, 2010
Notification Of Possible Opposition Sent To Ib
Jan 14, 2010
Notification Of Possible Opposition Created, To Be Sent To Ib
Jul 31, 2009
Notification Of Non-Final Action E-Mailed
Jul 31, 2009
Non-Final Action E-Mailed
Jul 31, 2009
Non-Final Action Written
Jul 28, 2009
Assigned To Examiner
Jan 7, 2009
Teas/Email Correspondence Entered
Jan 7, 2009
Correspondence Received In Law Office
Jan 7, 2009
Assigned To Lie
Dec 19, 2008
Teas Response To Office Action Received
Oct 29, 2008
Attorney/Dom.Rep.Revoked And/Or Appointed
Oct 29, 2008
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Sep 20, 2008
Refusal Processed By Ib
Aug 26, 2008
Non-Final Action Mailed - Refusal Sent To Ib
Aug 26, 2008
Refusal Processed By Mpu
Aug 26, 2008
Non-Final Action (Ib Refusal) Prepared For Review
Aug 25, 2008
Non-Final Action Written
Aug 15, 2008
Assigned To Examiner
Aug 15, 2008
New Application Entered In Tram
Aug 14, 2008
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
